JPMORGAN CHASE & CO - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 1 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$02000.0%0.00%
Q3 2022$0
-100.0%
200
-58.4%
0.00%
Q2 2021$1,000
-98.7%
481
-97.7%
0.00%
Q4 2020$77,00020,885
+115927.8%
0.00%
Q3 2020$0180.0%0.00%
Q2 2020$0
-100.0%
18
-100.0%
0.00%
Q1 2020$86,000
-49.4%
65,329
-30.0%
0.00%
Q4 2019$170,000
-57.4%
93,263
-32.5%
0.00%
Q3 2019$399,000
+120.4%
138,154
+94.9%
0.00%
Q1 2019$181,000
+9.0%
70,873
+18.8%
0.00%
Q4 2018$166,000
+325.6%
59,679
+1249.9%
0.00%
Q3 2018$39,0004,4210.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$68,0000.23%
Virtu Financial LLC 325,330$390,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 141,000$169,0000.02%
Clear Creek Financial Management, LLC 49,696$60,0000.01%
Palo Alto Investors LP 77,044$92,0000.01%
ACADIAN ASSET MANAGEMENT LLC 738,620$886,0000.00%
MARSHALL WACE, LLP 477,449$573,0000.00%
WADE G W & INC 35,000$42,0000.00%
TWO SIGMA ADVISERS, LP 599,471$719,0000.00%
BRYN MAWR TRUST Co 33,892$41,0000.00%
View complete list of IDERA PHARMACEUTICALS INC shareholders